These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 18175092)

  • 41. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.
    Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Conditioning the heart in cardiac surgery].
    Deja MA; Malinowski M
    Kardiol Pol; 2011; 69 Suppl 3():80-4. PubMed ID: 22125208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isoflurane and other commonly used anaesthetics do not protect the isolated buffer perfused mouse heart from ischemia-reperfusion injury.
    Galagudza M; Vaage J; Valen G
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):315-9. PubMed ID: 16620294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Signaling mediators modulated by cardioprotective interventions in healthy and diabetic myocardium with ischaemia-reperfusion injury.
    Saeid F; Aniseh J; Reza B; Manouchehr VS
    Eur J Prev Cardiol; 2018 Sep; 25(14):1463-1481. PubMed ID: 29442529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
    Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myocardial ischaemia reperfusion injury: the challenge of translating ischaemic and anaesthetic protection from animal models to humans.
    Xia Z; Li H; Irwin MG
    Br J Anaesth; 2016 Sep; 117 Suppl 2():ii44-ii62. PubMed ID: 27566808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Can any heart be preconditioned? Influence of aging and comorbidities on cardioprotection].
    Bilińska M
    Kardiol Pol; 2011; 69 Suppl 3():85-8. PubMed ID: 22125209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endogenous cardioprotection by ischaemic postconditioning and remote conditioning.
    Shi W; Vinten-Johansen J
    Cardiovasc Res; 2012 May; 94(2):206-16. PubMed ID: 22323534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ligand triggers of classical preconditioning and postconditioning.
    Gross ER; Gross GJ
    Cardiovasc Res; 2006 May; 70(2):212-21. PubMed ID: 16448635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microvascular preconditioning is not detectable by corrosion casting in the isolated perfused rat heart after 30 minutes of ischaemia.
    Arangannal A; McGarrity A; Wheatley DJ; Belcher PR
    Scand Cardiovasc J; 2008 Feb; 42(1):90-5. PubMed ID: 18273729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
    Andreadou I; Iliodromitis EK; Lazou A; Görbe A; Giricz Z; Schulz R; Ferdinandy P
    Br J Pharmacol; 2017 Jun; 174(12):1555-1569. PubMed ID: 28060997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphorylation of connexin-43 at serine 262 promotes a cardiac injury-resistant state.
    Srisakuldee W; Jeyaraman MM; Nickel BE; Tanguy S; Jiang ZS; Kardami E
    Cardiovasc Res; 2009 Sep; 83(4):672-81. PubMed ID: 19423616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of cardiac preconditioning with volatile anaesthetics.
    Hu ZY; Liu J
    Anaesth Intensive Care; 2009 Jul; 37(4):532-8. PubMed ID: 19681408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of clinical pathologies in myocardial injury following ischaemia and reperfusion.
    Galiñanes M; Fowler AG
    Cardiovasc Res; 2004 Feb; 61(3):512-21. PubMed ID: 14962481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardioprotection: chances and challenges of its translation to the clinic.
    Heusch G
    Lancet; 2013 Jan; 381(9861):166-75. PubMed ID: 23095318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Postconditioning: a brief review].
    Schipke JD; Kerendi F; Gams E; Vinten-Johansen J
    Herz; 2006 Sep; 31(6):600-6. PubMed ID: 17036192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
    Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
    Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postconditioning: current controversies and clinical implications.
    Mockford KA; Girn HR; Homer-Vanniasinkam S
    Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):437-42. PubMed ID: 19217807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiologists are living through exciting times. The example of postconditioning to protect the human heart during revascularization.
    Opie LH
    Ann Cardiol Angeiol (Paris); 2006 Apr; 55(2):64-5. PubMed ID: 16708987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.